Adial Pharmaceuticals (ADIL) Other Gross PP&E Adjustments (2022 - 2024)
Adial Pharmaceuticals' Other Gross PP&E Adjustments history spans 3 years, with the latest figure at -$81555.0 for Q3 2024.
- For Q3 2024, Other Gross PP&E Adjustments changed N/A year-over-year to -$81555.0; the TTM value through Dec 2024 reached -$137317.0, changed N/A, while the annual FY2023 figure was -$5816.0, 97.0% up from the prior year.
- Other Gross PP&E Adjustments for Q3 2024 was -$81555.0 at Adial Pharmaceuticals, down from -$55762.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$5816.0 in Q4 2023 and bottomed at -$233570.0 in Q1 2022.
- The 3-year median for Other Gross PP&E Adjustments is -$187113.0 (2022), against an average of -$147382.5.
- The largest YoY upside for Other Gross PP&E Adjustments was 97.0% in 2023 against a maximum downside of 22.84% in 2023.
- A 3-year view of Other Gross PP&E Adjustments shows it stood at -$193997.0 in 2022, then surged by 97.0% to -$5816.0 in 2023, then crashed by 1302.25% to -$81555.0 in 2024.
- Per Business Quant, the three most recent readings for ADIL's Other Gross PP&E Adjustments are -$81555.0 (Q3 2024), -$55762.0 (Q2 2024), and -$5816.0 (Q4 2023).